Stay updated with breaking news from Targeted Alpha Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MP0533: Phase 1 trial continues to demonstrate acceptable safety and antitumor activity up to cohort 6, dosing in cohort 7 ongoing, additional dose escalation cohorts being preparedRadio-DARPin...
MP0533: Phase 1 trial continues to demonstrate acceptable safety and antitumor activity up to cohort 6, dosing in cohort 7 ongoing, additional dose escalation cohorts being preparedRadio-DARPin Therapy (RDT): Lead
/PRNewswire/ -- IONETIX, a leading cyclotron technology and isotope manufacturing company, is pleased to announce the appointment of Douglas Boothe to its...
Rigging of the Cyclone® 30 XP in Poland completed with a further two sites in Germany and France already operational Louvain-la-Neuve, Belgium, December 12, 2023 – IBA ...
Rigging of the Cyclone 30XP in Poland completed with a further two sites in Germany and France already operational